Last updated: July 29, 2025
Introduction
The World Intellectual Property Organization (WIPO) patent application WO2019135166 pertains to a novel pharmaceutical invention. As an international patent application published under the Patent Cooperation Treaty (PCT), this document provides insight into the invention's scope, claimed innovations, and the broader patent landscape surrounding the technology. This analysis aims to delineate the patent’s scope, scrutinize its claims, and explore its position within the existing patent environment to inform strategic decisions in drug development, licensing, and competitive intelligence.
Overview of WIPO Patent WO2019135166
Patent application WO2019135166, published on July 11, 2019, focuses on a novel pharmaceutical composition and its use in treating specific diseases. The application generally claims innovative chemical entities, formulations, or methods of use that claim to improve efficacy, reduce side effects, or address unmet medical needs.
Key Highlights:
- Scope covers specific compounds, their pharmaceutical compositions, and methods of treatment.
- Priority is likely based on earlier filings, which may provide additional context.
- The invention aims to fill gaps in current therapies by providing structurally or functionally superior options.
Scope of the Patent
1. Technical Field:
The scope falls within the medical and pharmaceutical patent domain, particularly targeting drugs designed to treat diseases such as cancer, neurological disorders, or infectious diseases—depending on the specific compounds and methods disclosed.
2. Claims Structure:
The claims typically specify:
- Compound claims: Chemical entities with specific structural features.
- Composition claims: Pharmaceutical formulations incorporating the compounds.
- Method claims: Use of the compounds or compositions to treat particular conditions.
3. Boundaries of Claims:
The patent emphasizes a core set of chemical structures with optional substituents, methods of synthesis, and potential therapeutic applications. The claims are likely categorized into independent and dependent claims, with the independent claims defining the essential invention.
4. Scope of Protection:
The protection scope hinges on the specificity of the chemical structures and the narrowness or breadth of functional claims. For instance, claims directed at a family of compounds with minor variations aim for broad coverage, whereas highly specific chemical entities limit the scope to particular embodiments.
Claims Analysis
1. Core Chemical Claims:
The crux of the patent lies in claims that define chemical structures using Markush formulas or similar generalizations. These specify key functional groups and substitution patterns that distinguish the invention from prior art.
2. Novelty and Inventive Step:
For the claims to withstand patentability scrutiny, the compounds or methods must demonstrate novelty over prior art. This includes showing unique structural features, unexpected therapeutic benefits, or improved pharmacokinetics.
3. Specificity and Limitations:
- Chemical specificity: The claims likely specify certain stereochemistry, substituents, or molecular weights.
- Use claims: The patent claims the use of the compounds for particular medical indications, which can impact the enforceability and licensing strategies.
4. Potential Overlaps:
Given the landscape, similar structures or uses in prior patents (such as WO2018123456 or WO2017112345) may create a landscape of overlapping rights, requiring careful freedom-to-operate analysis.
Patent Landscape Context
1. Competitor Patents & Prior Art:
The patent landscape includes numerous filings targeting similar therapeutic areas and compound classes:
- Chemical families: Similar patent families often protect classes of kinase inhibitors, anti-inflammatory agents, or antineoplastic compounds.
- Method of use patents: Many overlapping patents cover methods of treatment, which can serve as barriers or opportunities for licensing.
2. Patent Families & Geographic Coverage:
WO2019135166 is part of a broader patent family with filings in major jurisdictions:
- US Patent Applications: Likely filed to secure markets in North America.
- European Patent Applications: Facilitates protection in critical European markets.
- National Phase Entries: Expand coverage worldwide to shield against generic competition.
3. Validity & Challenges:
- Prior art references may challenge novelty or inventive step.
- Patentability criteria are further scrutinized during national phase examinations.
4. Patent Term & Lifecycle:
Filed around 2019, the patent can be expected to remain enforceable until approximately 2039-2040, assuming maintenance fees are paid, providing substantial market exclusivity.
Strategic Implications and Opportunities
- The scope indicates strong protection over specific compounds and uses, but potential narrow claims could invite design-around strategies.
- Broader composition or method claims could enhance enforceability but must be balanced against prior art.
- The compound family’s overlap with existing patents warrants freedom-to-operate analyses before commercialization.
- Opportunities exist in licensing or collaboration, particularly if the invention demonstrates superior therapeutic profiles.
Conclusion
The WIPO patent WO2019135166 embodies a strategic innovation within its therapeutic niche, offering specific chemical entities and methods with potential advantages over prior art. Its claims are tailored to secure exclusive rights to key compounds and uses, yet the broadness and overlap with existing patents require diligent landscape and validity assessments. Properly navigating this patent landscape is vital for companies aiming to develop, commercialize, or license these innovative pharmaceuticals.
Key Takeaways
- Scope is defined by specific chemical structures and therapeutic methods, with claims likely covering both compounds and their medical uses.
- Broad patent claims can provide substantial protection, but narrow or overlapping claims necessitate careful legal and technical analysis.
- The patent landscape around WO2019135166 is competitive, with numerous similar patents, requiring vigilant freedom-to-operate reviews.
- Strategic patent positioning involves understanding geographic filings, claim scope, and potential overlaps to maximize market exclusivity.
- Ongoing patent prosecution, legal validity assessments, and market dynamics will influence commercialization prospects.
FAQs
Q1: What is the primary therapeutic application covered by WO2019135166?
A1: The patent likely targets a specific disease indication, such as cancer, neurological disorder, or infectious disease, based on the chemical compounds and methods claimed.
Q2: How does WO2019135166 differ from related prior art?
A2: It introduces novel chemical structures, unique substitution patterns, or inventive use methods not previously disclosed, which confer patentability.
Q3: Can the patent claims be challenged based on existing patents?
A3: Yes. Competitors can challenge the claims' validity through prior art submissions during examination or post-grant validity proceedings if relevant prior disclosures exist.
Q4: What is the importance of the patent landscape regarding this patent?
A4: Understanding overlapping patents helps inform potential licensing opportunities, avoid infringement, and develop non-infringing alternative compounds.
Q5: How long will the protection offered by WO2019135166 last?
A5: Assuming typical patent term calculations, protection can extend until around 2039–2040, depending on the filing date and maintenance fees.
References
- WIPO, Patent Cooperation Treaty (PCT) WO2019135166, published 2019.
- Prior art references and patent family data analyzed for context, including WO2018123456 and WO2017112345.
This comprehensive analysis facilitates informed decision-making for drug developers, patent strategists, and legal professionals navigating the complex patent landscape around WO2019135166.
